<DOC>
	<DOCNO>NCT00209586</DOCNO>
	<brief_summary>This study design demonstrate AQUAVAN® effective provide adequate sedation patient undergo flexible bronchoscopy well assess safety profile AQUAVAN versus midazolam . Prior procedure , patient receive fentanyl citrate pain management follow five minute later either AQUAVAN® Injection midazolam HCl sedation . During procedure , study personnel ass patient 's vital sign depth sedation . After procedure , patient , physician , evaluator ask complete satisfaction survey .</brief_summary>
	<brief_title>A Study AQUAVAN® Injection Sedation Elderly Patients Undergoing Flexible Bronchoscopy</brief_title>
	<detailed_description>This randomize , open-label study design ass safety efficacy AQUAVAN® Injection versus midazolam HCl follow pretreatment analgesic , fentanyl citrate injection , produce sedation patient undergo flexible bronchoscopy procedure . Randomization stratify site . Following completion pre-procedure sedation assessment , patient randomly assign 1 2 i.v . treatment group 3:1 ( AQUAVAN® Injection : midazolam HCl ) allocation ratio . All study patient , irrespective treatment group assignment , receive fentanyl citrate injection analgesic pretreatment . Supplemental dos fentanyl citrate injection may administer patient report pain inadequate analgesia present demonstrate increased heart rate and/or blood pressure presence adequate sedation . At time fentanyl citrate injection administer increase sedation level . AQUAVAN® Injection midazolam HCl administer induce state adequate sedation , define Modified Observer 's Assessment Alertness / Sedation ( OAA/S ) score 4 less . Supplemental dos administer increase depth duration sedation . Supplemental dos administer Modified OAA/S score 2 less purposeful response stimulation . The depth sedation measure Modified OAA/S scale , validated measure . Patient Investigator assessment use confirm depth sedation provide met goal sedation , reduction anxiety reduce awareness .</detailed_description>
	<mesh_term>Fospropofol</mesh_term>
	<criteria>1 . Patient provide signed/dated Informed Consent HIPAA Authorization receive full explanation extent nature study . 2 . Patient least 18 year age time screen . 3 . Female patient must surgically sterile , postmenopausal , pregnant lactating , must use acceptable method birth control least 1 month prior dose , negative urine pregnancy test result screen predosing period . 4 . Patient meet American Society Anesthesiologists ( ASA ) Physical Status Classification I III . 1 . Patient history allergic reaction hypersensitivity anesthetic agent , narcotic benzodiazepine . 2 . Patient meet nil per o ( NPO ) status per ASA Guideline institution 's guideline . 3 . Patient condition ( ) , opinion Investigator , could interfere appropriate airway management . 4 . Patient require artificial ventilation prior initiation bronchoscopy admit intensive care unit . 5 . Patient history mental visual impairment would permit successful measurement cognitive evaluation . 6 . Patient unwilling adhere pre postprocedural instruction . 7 . The use fentanyl midazolam contraindicate patient . 8 . Patient participate investigational study within 1 month prior study start .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Bronchoscopy</keyword>
	<keyword>Sedation</keyword>
</DOC>